Skip to main content
Premium Trial:

Request an Annual Quote

Agena Bioscience, Molecular Health Partner for MassArray Interpretation

NEW YORK (GenomeWeb) – Agena Bioscience and Molecular Health said today that they have entered into a strategic partnership under which Molecular Health will use its MH Guide analysis platform to interpret raw data generated by Agena's MassArray system.

The relationship is part of Agena's MassArray Insights reporting network, under which the firm seeks to collaborate with various molecular analysis platform providers.

Specific terms of the agreement were not disclosed, but the firms said that they plan to "cooperate and collaborate with their respective customer bases."

According to Agena CEO Pete Dansky, Moleuclar Helath's data interpretation capabilities answer a currently unmet need for customers using the MassArray platform in the context of laboratory developed tests.

"Many of our customers with [LDTs] have been interested in additional resources for result interpretation. We believe that Molecular Health's data interpretation applications … can greatly streamline the data analysis and interpretation workflow for these customers," Dansky said in a statement.

Users of the MassArray system in the clinical testing sphere include Intermountain Healthcare and Assurex Health.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.